Ceretropic/Nootropics Depot Pipeline Update?

Essentially when we lost our processing on Ceretropic last September, I put a freeze on all of Ceretropic's R&D. We did had some already in the pipeline that we finished, and have been holding till I give the okay for sale. I have also been quietly working on others in the background that I do not talk about. However, for all intents and purposes, Ceretropic was frozen from a public perspective, till we worked through our site/payment issue. Now that we have rectified most of those issues, and our new site/processors are up, we are going to release the products we have been holding, and start working on some new ones I have been holding off on. Orexin-A, P21, thymalin, methylene blue solution, and N-Acetyl Selank Amidate spray are all going up soon. I just need to get the okay from everyone on my team that our new site is ready.

During the past year, we have mostly focused on the expansion of Nootropics Depot. We put a mini freeze on releasing new products when we lost our card processing two weeks ago. However, now that we have that rectified, we are going to step back up. We have a bunch of products in the pipeline or already completed on the ND side of things. So those will be going up shortly. We also just put up some cool flavorings for supplements. Essentially they are just premixed flavor powders that you can mix into your drinks/shakes that you mix supplements into. It will allow you to make them more palatable, which is something that many people complain about. We'll be releasing a bunch new natural products on ND as well. So look out for that.

We have a bunch of other new products on the Ceretropic side that we will be starting, or resuming, work on. Our main focus is the ability to reliably and accurately ensure that we can analyze the identity and purity of these new compounds. That's why we have not released 7,8-DHF yet. Everything sold on the market so far has not matched the Sigma Aldrich reference standard, and we are trying to figure out why. There are a bunch of other substituted flavones out there, and I have a feeling what is being sold as 7,8-DHF currently is actually 5,7,8-trihydroxyflavone, also called Norwogonin. This would explain why all our tests are showing extra hydroxyl groups, and why it still subjectively feels like a TrkB agonist. Now that we have the analytical capabilities that nobody else in the space has, I want to be absolutely sure things are exactly as they are supposed to be, and pure. I do not blindly trust outside labs anymore without hard analytical results/methods that we can recreate. This means that it may take us longer to bring out novel products than the other vendors either just trusting the supplier COAs, or trusting a 3rd party lab without actual hard data. It's also why we have a few products out of stock for so long, as we are working to develop and validate in-house analytical methods for them. So while it may seem like it takes us a long time to bring certain things out, at least you'll know that if we release something, it's correct and pure.